
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
Neife Aparecida Guinaim dos Santos, Rafaela Scalco Ferreira, Antônio C. Santos
Food and Chemical Toxicology (2019) Vol. 136, pp. 111079-111079
Open Access | Times Cited: 156
Neife Aparecida Guinaim dos Santos, Rafaela Scalco Ferreira, Antônio C. Santos
Food and Chemical Toxicology (2019) Vol. 136, pp. 111079-111079
Open Access | Times Cited: 156
Showing 1-25 of 156 citing articles:
Cisplatin in cancer treatment
Andrea Romani
Biochemical Pharmacology (2022) Vol. 206, pp. 115323-115323
Closed Access | Times Cited: 181
Andrea Romani
Biochemical Pharmacology (2022) Vol. 206, pp. 115323-115323
Closed Access | Times Cited: 181
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117
Cisplatin in Liver Cancer Therapy
Sae Hamaya, Kyoko Oura, Asahiro Morishita, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10858-10858
Open Access | Times Cited: 41
Sae Hamaya, Kyoko Oura, Asahiro Morishita, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10858-10858
Open Access | Times Cited: 41
Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies
Qing Tang, Xianren Wang, Xin Jin, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 163, pp. 60-71
Closed Access | Times Cited: 91
Qing Tang, Xianren Wang, Xin Jin, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 163, pp. 60-71
Closed Access | Times Cited: 91
Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
Dobrina Tsvetkova, Stefka Ivanova
Molecules (2022) Vol. 27, Iss. 8, pp. 2466-2466
Open Access | Times Cited: 63
Dobrina Tsvetkova, Stefka Ivanova
Molecules (2022) Vol. 27, Iss. 8, pp. 2466-2466
Open Access | Times Cited: 63
Is Autophagy Always a Barrier to Cisplatin Therapy?
Jingwen Xu, David A. Gewirtz
Biomolecules (2022) Vol. 12, Iss. 3, pp. 463-463
Open Access | Times Cited: 43
Jingwen Xu, David A. Gewirtz
Biomolecules (2022) Vol. 12, Iss. 3, pp. 463-463
Open Access | Times Cited: 43
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
Victoria A. Sanchez, Megan M. Shuey, Paul C. Dinh, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 12, pp. 2211-2226
Open Access | Times Cited: 24
Victoria A. Sanchez, Megan M. Shuey, Paul C. Dinh, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 12, pp. 2211-2226
Open Access | Times Cited: 24
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 23
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 23
Advances in Understanding Cisplatin-Induced Toxicity: Molecular Mechanisms and Protective Strategies
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106939-106939
Open Access | Times Cited: 8
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106939-106939
Open Access | Times Cited: 8
Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment
Hanan Seddiek, Mira Hanna, Amany Hamoud, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Hanan Seddiek, Mira Hanna, Amany Hamoud, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Clinical applications of nanomedicines in lung cancer treatment
Mohammad Norouzi, Pierre Hardy
Acta Biomaterialia (2020) Vol. 121, pp. 134-142
Closed Access | Times Cited: 62
Mohammad Norouzi, Pierre Hardy
Acta Biomaterialia (2020) Vol. 121, pp. 134-142
Closed Access | Times Cited: 62
Beta-Blockers and Cancer: Where Are We?
Rita Peixoto, Maria de Lourdes Pereira, Miguel Oliveira
Pharmaceuticals (2020) Vol. 13, Iss. 6, pp. 105-105
Open Access | Times Cited: 51
Rita Peixoto, Maria de Lourdes Pereira, Miguel Oliveira
Pharmaceuticals (2020) Vol. 13, Iss. 6, pp. 105-105
Open Access | Times Cited: 51
Regulation of ACSL4-Catalyzed Lipid Peroxidation Process Resists Cisplatin Ototoxicity
Feinan He, Xiaotong Huang, Guokun Wei, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 36
Feinan He, Xiaotong Huang, Guokun Wei, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 36
Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs
Ademola C. Famurewa, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, et al.
Life Sciences (2022) Vol. 305, pp. 120789-120789
Closed Access | Times Cited: 32
Ademola C. Famurewa, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, et al.
Life Sciences (2022) Vol. 305, pp. 120789-120789
Closed Access | Times Cited: 32
Ginsenosides in cancer: A focus on the regulation of cell metabolism
Yao Wang, Yunfeng Guan
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113756-113756
Open Access | Times Cited: 31
Yao Wang, Yunfeng Guan
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113756-113756
Open Access | Times Cited: 31
Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?
Jelena Katanić, Dragica Selaković, Gvozden Rosić
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14574-14574
Open Access | Times Cited: 17
Jelena Katanić, Dragica Selaković, Gvozden Rosić
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14574-14574
Open Access | Times Cited: 17
Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: Imperative roles of AMPK/Akt/CREB/ BDNF signaling cascades
Abdulla M.A. Mahmoud, Eman M. Mantawy, Sara A. Wahdan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114238-114238
Open Access | Times Cited: 16
Abdulla M.A. Mahmoud, Eman M. Mantawy, Sara A. Wahdan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114238-114238
Open Access | Times Cited: 16
Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review
Masoud Najafi, Shima Tavakol, Ali Zarrabi, et al.
Archives of Physiology and Biochemistry (2020) Vol. 128, Iss. 6, pp. 1438-1452
Closed Access | Times Cited: 48
Masoud Najafi, Shima Tavakol, Ali Zarrabi, et al.
Archives of Physiology and Biochemistry (2020) Vol. 128, Iss. 6, pp. 1438-1452
Closed Access | Times Cited: 48
Autophagy-dependent ferroptosis contributes to cisplatin-induced hearing loss
Bingquan Jian, Jiaqi Pang, Hao Xiong, et al.
Toxicology Letters (2021) Vol. 350, pp. 249-260
Closed Access | Times Cited: 34
Bingquan Jian, Jiaqi Pang, Hao Xiong, et al.
Toxicology Letters (2021) Vol. 350, pp. 249-260
Closed Access | Times Cited: 34
Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature
Angeles Citlali Zavala-Valencia, Liliana Velasco‐Hidalgo, Armando Martínez-Ávalos, et al.
Biologics (2024) Vol. Volume 18, pp. 7-19
Open Access | Times Cited: 5
Angeles Citlali Zavala-Valencia, Liliana Velasco‐Hidalgo, Armando Martínez-Ávalos, et al.
Biologics (2024) Vol. Volume 18, pp. 7-19
Open Access | Times Cited: 5
Ondansetron attenuates cisplatin-induced behavioral and cognitive impairment through downregulation of NOD-like receptor inflammasome pathway
Mennat-Allah M. Hassan, Sara A. Wahdan, Reem N. El‐Naga, et al.
Toxicology and Applied Pharmacology (2024) Vol. 485, pp. 116875-116875
Closed Access | Times Cited: 5
Mennat-Allah M. Hassan, Sara A. Wahdan, Reem N. El‐Naga, et al.
Toxicology and Applied Pharmacology (2024) Vol. 485, pp. 116875-116875
Closed Access | Times Cited: 5
Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy
Victoria A. Sanchez, Paul C. Dinh, Patrick O. Monahan, et al.
JAMA Oncology (2024) Vol. 10, Iss. 7, pp. 912-912
Closed Access | Times Cited: 5
Victoria A. Sanchez, Paul C. Dinh, Patrick O. Monahan, et al.
JAMA Oncology (2024) Vol. 10, Iss. 7, pp. 912-912
Closed Access | Times Cited: 5
Scopoletin as a Cardioprotective Agent Against Cisplatin-Induced Oxidative Stress and Inflammation
Esam Qnais, Omar Gammoh, Yousra Bsieso, et al.
Phytomedicine Plus (2025), pp. 100738-100738
Open Access
Esam Qnais, Omar Gammoh, Yousra Bsieso, et al.
Phytomedicine Plus (2025), pp. 100738-100738
Open Access
Captopril attenuates oxidative stress and neuroinflammation implicated in cisplatin-induced cognitive deficits in rats
Fatma Mostafa, Eman M. Mantawy, Riham S. Said, et al.
Psychopharmacology (2025)
Open Access
Fatma Mostafa, Eman M. Mantawy, Riham S. Said, et al.
Psychopharmacology (2025)
Open Access
Polydopamine Nanohydrogel Decorated Adhesive and Responsive Hierarchical Microcarriers for Deafness Protection
Hong Chen, Hui Zhang, Jiayi Li, et al.
Advanced Science (2025)
Open Access
Hong Chen, Hui Zhang, Jiayi Li, et al.
Advanced Science (2025)
Open Access